Figure-2.
The percentage of eggs that hatched at a discriminating dose (DD) of 0.1 µg/mL thiabendazole and eggs that developed to third stage (infective) larvae in the DD of thiabendezole (0.02 μg/mL) in the macro-agar larval development test.
The percentage of eggs that hatched at a discriminating dose (DD) of 0.1 µg/mL thiabendazole and eggs that developed to third stage (infective) larvae in the DD of thiabendezole (0.02 μg/mL) in the macro-agar larval development test.